Restless legs drug may ease opioid withdrawal, study halted early
NCT ID NCT04759703
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tested whether pramipexole, a drug for restless legs syndrome, could reduce both restless legs and ongoing withdrawal symptoms in people recovering from opioid use disorder. The goal was to help them stay in treatment. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gavin Foundation Clinical Stabilization Services
Quincy, Massachusetts, 02170, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.